Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Prolactin may be important for skin growth and immune function.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Metformin can cause hair loss in some women with PCOS.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Hirsutism in teen girls is common, usually harmless, but can sometimes signal serious issues and is treatable.

Ovarian drilling surgery is not clearly better than medical treatments for PCOS symptoms.